Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness

• Published in: Toxins 2024-01, Vol.16 (1), p.28
• Main Authors: Marani, Andrea, Gioacchini, Helena, Paolinelli, Matteo, Bobyr, Ivan, Martina, Emanuela, Radi, Giulia, Diotalallevi, Federico, Campanati, Anna
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Alcoholism; Anesthesia; Botulinum toxin; Botulinum toxin type A; Botulinum Toxins, Type A - therapeutic use; Care and treatment; Clinical medicine; Clinical trials; cryoanalgesia; Diagnosis; Disease; Dosage and administration; Exocrine glands; Humans; Hyperhidrosis; Hyperhidrosis - drug therapy; Injection; Iodine; Lidocaine; Lidocaine - therapeutic use; Liposomes; NRS scale; Pain; Pain - drug therapy; Pain Management; palmar hyperhidrosis; Patient outcomes; Patients; Quality of life; Questionnaires; Spinal cord; Statistical analysis; Sweating; Topical application; Toxins; Treatment Outcome
• ISSN: 2072-6651; 2072-6651
• DOI: 10.3390/toxins16010028

Primary palmar hyperhidrosis (PPH) constitutes a debilitating condition that profoundly impacts the social, functional, and occupational aspects of individuals. The intradermal administration of botulinum toxin type A (BoNT-A) stands as an established therapeutic approach for PPH, albeit one frequently accompanied by considerable pain, posing challenges for patient tolerance. Our study aimed to assess the efficacy of combining cryoanalgesia spray (CA) with topical anesthesia utilizing a cream containing liposomal lidocaine at a concentration of 40 mg/g, with the objective of mitigating the pain associated with intradermal BoNT-A injection for PPH treatment. Nineteen participants, aged ≥18 years and afflicted with severe PPH, were enrolled in a double-blind randomized vehicle-controlled trial. Patient-perceived pain during the procedure was quantified using the Numeric Rating Scale (NRS). Statistical analysis was applied to the collected data. The combination of CA and the topical application of liposomal lidocaine during BoNT-A treatment for PPH resulted in diminished pain compared to CA alone and the combination of CA with the application of a basic cream. Topical anesthesia through the application of a liposomal lidocaine-containing cream emerged as a facile, secure, and efficacious approach for alleviating the pain associated with intradermal BoNT-A injection in PPH treatment. Furthermore, it demonstrated compatibility with CA, thereby offering a comprehensive strategy for pain management during BoNT-A administration.